Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply

Vince B. C. Biemans*, Frank Hoentjen, Marieke J. Pierik

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)1255-1256
Number of pages2
JournalAlimentary Pharmacology & Therapeutics
Issue number7
Publication statusPublished - Oct 2020

Cite this